Ivabradine Versus Beta-Blockers in Patients with Conduction Abnormalities or Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting

QR Code

Ivabradine Versus Beta-Blockers in Patients with Conduction Abnormalities or Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting

None

Saved in:

Bibliographic Details
Main Authors:	Iliuta, Luminita, Enache, Roxana
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/30213
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
by: V. V. Kashtalap, et al.
Published: (2019-11-01)

Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19
by: V. I. Podzolkov, et al.
Published: (2022-08-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

Inhospital changes of left ventricular diastolic function in patients undergoing coronary bypass surgery
by: A. R. Mingalimova, et al.
Published: (2022-09-01)

Early Results After Coronary Artery Bypass Grafting in Patients With Severe Ischemic Left Ventricular Dysfunction
by: M. K. Mazanov, et al.
Published: (2020-10-01)

Effectiveness of beta-blockers in the treatment of idiopathic premature ventricular contractions in children
by: K. B. Alekseeva, et al.
Published: (2022-08-01)

Long-term benefit of vasodilating beta-blockers in acute myocardial infarction patients with mildly reduced left ventricular ejection fraction.
by: Ki Yung Boo, et al.
Published: (2025-01-01)

Long-term benefit of vasodilating beta-blockers in acute myocardial infarction patients with mildly reduced left ventricular ejection fraction
by: Ki Yung Boo, et al.
Published: (2025-01-01)

Characteristics of left ventricular and cardiac hemodynamic remodeling after on-pump or off-pump coronary artery bypass grafting
by: S. D. Mayanskaya, et al.
Published: (2023-07-01)

High sympathetic tone in development of the left ventricle hypertrophy and beta-blockers for regression
by: О. D. Ostroumova, et al.
Published: (2018-09-01)

IVABRADINE EFFECTIVENESS IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AFTER CORONARY ARTERY BYPASS GRAFT SURGERY
by: I. V. Kochetkova, et al.
Published: (2014-04-01)

Role of dihydropyridine calcium channel blockers in coronary bypass surgery using the radial artery graft
by: V. V. Zatolokin, et al.
Published: (2022-09-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
by: K. G. Adamyan, et al.
Published: (2015-11-01)

Beta-Blockers and Coronary Flow Reserve
by: Galderisi, Maurizio
Published: (2011)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

Impact of regional anesthesia on left and right ventricular performance after off-pump coronary artery bypass grafting: randomized controlled study
by: K. V. Paromov, et al.
Published: (2024-08-01)

The impact of comorbidities and age on the nosocomial outcomes of patients undergoing coronary artery bypass grafting
by: O. L. Barbarash, et al.
Published: (2019-04-01)

The Effects of Lidocaine on Reperfusion Ventricular Fibrillation During Coronary Artery - Bypass Graft Surgery
by: Mahli, Ahmet, et al.
Published: (2012)

Analysis of the prevalence and role of maladaptive left ventricular remodeling in the risk of early renal graft dysfunction
by: R. A. Ibadov, et al.
Published: (2025-03-01)

Beta-blockers. What about goes unsaid?
by: I. A. Latfullin
Published: (2008-10-01)

Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01)

COMORBIDITY IN CORONARY HEART DISEASE PATIENTS UNDERGOING BYPASS GRAFTING: AN EXPERIENCE OF TWO SURGERY CENTERS
by: N. L. Barbarash, et al.
Published: (2017-03-01)

MEDICAL MYOCARDIAL PROTECTION IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING CORONARY ARTERY BYPASS GRAFTING
by: L. G. Gelis, et al.
Published: (2012-06-01)

Antioxidant protection system before and after coronary bypass surgery in coronary heart disease patients with left ventricular dysfunction
by: L. A. Bokeriya, et al.
Published: (2004-12-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Impact of High Epidural Block on Left Ventricular Myocardial Function after Aortocoronary Bypass Surgery
by: L. A. Kolevatova, et al.
Published: (2006-02-01)

Hypotensive efficacy and cerebroprotective action of beta blocker metoprolol
by: N. L. Afanasyeva, et al.
Published: (2005-02-01)

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
by: A. A. Aleksandrov, et al.
Published: (2016-01-01)

High-Dose Insulin Euglycemic Therapy in Concomitant Beta-Blocker and Calcium Channel Blocker Overdose
by: Varun Roperia MD, et al.
Published: (2025-07-01)

Impact of short-term physical prehabilitation on psychophysiological parameters in patients undergoing coronary artery bypass grafting
by: О. A. Trubnikova, et al.
Published: (2020-12-01)

Beta-blocker and calcium-channel blocker therapy in patients with cardiovascular pathologies during post-COVID period
by: A. G. Arutyunov, et al.
Published: (2022-01-01)

ENDOTHELIAL DYSFUNCTION AND ROLE NITRATES AND BETA-BLOCKERS IN ITS CORRECTION IN ISCHEMIC HEART DISEASE
by: A. N. Britov
Published: (2016-05-01)

Microcirculation disorders and structural and functional left ventricular abnormalities in patients with type 1 diabetes complicated by ketoacidosis
by: N. V. Mukhа, et al.
Published: (2020-12-01)

Left ventricular hemodynamic forces: gaining insight into left ventricular function
by: Alessandro Salustri, et al.
Published: (2025-05-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
by: E. V. Kokhan, et al.
Published: (2021-07-01)

Cardiac Myocardial Disease States Cause Left Ventricular Remodeling with Decreased Contractility and Lead to Heart Failure;Interventions by Coronary Arterial Bypass Grafting and Surgical Ventricular Restoration Can Reverse LV Remodeling with Improved Cont
by: Ghista, Dhanjoo N., et al.
Published: (2012)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)

THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
by: R. I. Striuk, et al.
Published: (2015-12-01)